Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Divalproex Sodium ER in Bipolar Depression
NCT00194116Phase 3Completed
- Sponsor
- University Hospitals Cleveland Medical Center
- Start
- Sep 2004
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in bipolar disorder (BD) comparing Divalproex Sodium ER with Placebo (2 arms). Primary endpoint: Montgomery-Asberg Depression Rating Scale at 6 weeks. Started Sep 2004; status: completed.
02
Drugs
divalproex sodium
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00194116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00194116.